Helen Ross McNabb Center
Knoxville, Tennessee, 37917, United States
NCT Number: NCT00559572
This study will evaluate the impact of motivational guidance to exercise on people with schizophrenia, based on their participation in a walking program.
Looking for future studies?
Notify Me22 year and older
All sexes
Interventional
Not applicable
Knoxville, Tennessee, 37917, United States
Schizophrenia is a chronic brain disorder that affects about 1% of Americans. People with schizophrenia experience extreme paranoia, often claiming that they hear voices not heard by others and that others are invading or controlling their minds with the intent to hurt them. More specific symptoms include hallucinations, delusional behaviors, disordered movements, and decreased ability to comprehend and apply information to everyday activities. The severity of these symptoms makes self-care and regular exercise difficult for people with schizophrenia. The fatality rate from diabetes, heart disease, and other obesity-related illnesses is significantly higher in people with schizophrenia. Exercise is known to reduce health problems associated with obesity, yet few studies have encouraged exercise as a treatment method for improving the health of those with schizophrenia. Furthermore, the long-term physical and mental effects of consistent exercise on people with schizophrenia are not well-known. This study will evaluate the impact of motivational guidance to exercise on people with schizophrenia, based on their attendance, persistence, and compliance to a walking program.
Participants in this study will be randomly assigned to one of two groups. Both groups will continue their regular medications and treatments throughout the study. Upon entry, members of both groups will complete the same two forms concerning attitudes toward exercise. Group 1 participants will attend weekly 1-hour exercise information sessions for 4 weeks. Group 2 participants will attend weekly 1-hour general health information sessions for the same 4 weeks. Participants of both groups will then take part in identical 16-week walking programs. The walking program will consist of three 30- to 50-minute walks per week, including 10 minutes of warm up and 10 minutes of cool down stretching. All participants will gradually increase their walking time from 5 minutes to 30 minutes during the program. At the completion of the walking programs, participants of both groups will complete repeat forms about their attitudes toward exercise. There will be no follow-up visits for the participants.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Motivational group sessions include 4 weeks of weekly 1-hour exercise information sessions.
Time and attention control group sessions include 4 weeks of weekly 1-hour general health information sessions.
Time frame: Measured at Week 16
Time frame: Measured at Weeks 4,8, 12 & 16
Time frame: Measured at Weeks 4,8,12 & 16
Time frame: Measured at Weeks 4,8,12 and 16
The University of Tennessee, Knoxville
Other
Motivating Persons With Schizophrenia to Exercise
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02815813
Behavior, Bipolar Disorder
New Britain, Connecticut, United States
View Trial DetailsNCT01324973
Adherence Interventions, Affective Disorders, Psychotic
Los Angeles, California, United States
View Trial DetailsNCT06572657
Behavior, Computerized Cognitive Stimulation
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT06574893
Behavior, Mental Disorders
Istanbul, Turkey (Türkiye)
View Trial Details